Ionis therapeutics stock
Web11 apr. 2024 · Discover historical prices for IONS stock on Yahoo Finance. View daily, weekly or monthly format back to when Ionis Pharmaceuticals, Inc. stock was issued. Web28 mrt. 2024 · CytomX Therapeutics (CTMX) In a report released yesterday, Etzer Darout from BMO Capital maintained a Hold rating on CytomX Therapeutics, with a price target …
Ionis therapeutics stock
Did you know?
Web6 apr. 2024 · The average twelve-month price prediction for Ionis Pharmaceuticals is $45.17 with a high price target of $67.00 and a low price target of $27.00. Learn more on IONS's … Web13 apr. 2024 · The company’s stock has been forecasted to trade at an average price of $8.32 over the course of the next 52 weeks, with a low of $4.00 and a high of $16.00. Based on these price targets, the low is 28.7% off current price, whereas the price has to move -185.2% to reach the yearly target high.
Web10 apr. 2024 · To see how Fate Therapeutics Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: FATE stock’s performance was 6.36% in the latest trading, and -85.40% in the past year, while Ionis Pharmaceuticals Inc. (IONS) has traded 1.86% on the day and positioned -2.61% lower than it was a year … WebPharmaceuticals, Inc. “Akcea,” the Akcea logo, and other trademarks or service marks of Akcea Therapeutics, Inc. appearing in this report are the property of Akcea …
WebIonis Pharmaceuticals, Inc. (IONS) Stock Price, News, Quote & History - Yahoo Finance Personal Finance U.S. markets closed S&P Futures 0.00(0.00%) Dow Futures 33,683.00 … WebThe biotech company Ionis Pharmaceuticals Inc trades as IONS stock on the Nasdaq All Markets. Ionis is THE leading innovator in RNA-targeted therapeutics and was …
Web10 jun. 2024 · Ionis and partner Biogen brought Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide …
WebIonis is focused on delivering RNA-targeted therapeutics with transformational potential. Our antisense oligonucleotide drug discovery platform has transformed the lives of … something for 8 year old girlssomething flying in front of my eyeWeb1 sep. 2024 · Ionis Pharmaceuticals has agreed to purchase the remaining outstanding shares in Akcea Therapeutics for a total cash consideration of about $500m, or $18.15 per share. Ionis expects to benefit via financial upside from Akcea’s pipeline and commercial medicines. Credit: Ionis Pharmaceuticals. something for a 10 year old girlWeb16 dec. 2024 · Ionis ( NASDAQ: IONS) is currently trading at $29.73 while it has an intrinsic value of $49.27. The short-term catalyst that will move this stock in 2024 is increased market share for Spinraza.... small christmas tree deliveryWebStock quote Ionis Pharmaceuticals, Inc. Stock quote Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 Week Low Stock Chart … something for a 13 year old girlWeb17 mrt. 2024 · Ionis Pharmaceuticals Stock (NASDAQ: IONS) stock price, news, charts, stock research, profile. small christmas trees at hobby lobbyWebIonis Pharmaceuticals stock price target cut to $76 from $90 at BMO Capital Mar. 23, 2024 at 8:51 a.m. ET by Tomi Kilgore Biotech and Pharma Ionis Stock Plunges as Monitoring … small christmas trees artificial target